Track topics on Twitter Track topics that are important to you
LivaNova PLC, a market─leading medical technology company, announced the first implanted patient and official launch of a global registry to evaluate the use of LivaNova's Vagus Nerve Stimulation
LivaNova has obtained approval from Japan's Ministry of Health, Labor and Welfare for its Perceval sutureless aortic heart va -More-
A global outcomes registry for evaluating LivaNova's Vagus Nerve Stimulation Therapy system as a treatment for patients with -More-
LivaNova’s PRELUDE first-in-human study assessed the TMVR system for treating moderate to severe mitral regurgitation (MR) using a transseptal approach. This is a less invasive approach that uses T...
In another safety communication from US FDA on LivaNova's Stockert 3T Heater-Cooler Systems, the agency adds recommendations for providers and...
LivaNova has secured 510(k) clearance from the FDA for its MEMO 4D semirigid mitral annuloplasty ring, which is intended to t -More-
LivaNova has completed a 20-patient feasibility study of its Caisson transcatheter mitral valve replacement device that, acco -More-
LivaNova has implemented labeling changes and a design correction to its Stockert 3T Heater-Cooler System, designed for contr -More-
SummaryMany novel therapeutic options for depression exist that are either not mentioned in clinical guidelines or recommended only for use in highly specialist services. The challenge faced by clinic...
Sutureless aortic valve prostheses are gaining popularity due to the substantial reduction in cross-clamp time. In this study, we report our observations on the cusp-fluttering phenomenon of the Perce...
Several indications for sutureless aortic valve replacement (SU-AVR) have been a matter of debate. We evaluated our experience with Perceval-S (LivaNova group, Saluggia, Italy) SU-AVR in patients with...
The Perceval valve (LivaNova, London, United Kingdom) is a collapsible, sutureless bioprosthetic aortic valve. This novel design is well suited for minimally invasive approaches and has particular adv...
A global outbreak of infections due to Mycobacterium chimaera has been linked to the LivaNova (formerly Sorin) 3 T heater-cooler units (HCUs). We performed a study to investigate M. chimaera from HC...
This is a prospective, interventional, multi-center trial to report the overall incidence of reduced leaflet motion identified by CT imaging in patients receiving a commercially approved L...
LivaNova PLCÂ is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Li...
LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical devic...
We have published hundreds of LivaNova news stories on BioPortfolio along with dozens of LivaNova Clinical Trials and PubMed Articles about LivaNova for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LivaNova Companies in our database. You can also find out about relevant LivaNova Drugs and Medications on this site too.